Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block vs IV Lidocaine for Kidney Transplant
NCT03843879Phase 3Unknown
- Sponsor
- Benaroya Research Institute
- Start
- Apr 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain, sponsored by Benaroya Research Institute. Status: unknown.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03843879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03843879.